Objective: The pharmacodynamic properties of the novel ketolide (a new class of macrolide) antibiotic, HMR 3004, were investigated by studying time-kill kinetics and postantibiotic effect.
INTRODUCTION
The ketolide H M R 3004 belongs to a new 14-membered ring macrolide class of antibiotics which are characterized by a 3-keto group on the erythronolide A ring instead of the a-L-cladinose moiety [l] . The ketolides possess the antibacterial spectrum of erythromycin A [2] , and H M R 3004 has demonstrated outstanding activity against multiresistant pneumococci and activity against Haemophilus irguenzae, Stueptococcus yneumoniae and the enterococci. Against strains susceptible to macrolides, the activity of H M R 3004 is one to two orders of magnitude higher than that of clarithromycin and erythromycin [3] .
Pharmacodynamic parameters have become increasingly important for the determination of optimal dosing schedules of antibiotics. The in vitro pharmacodynamic parameters of an antimicrobial include time kill kinetics and postantibiotic effect (PAE). Time kill curves are pharmacodynamic examples of bactericidal activity expressed as rate of killing by a fixed concentration of antimicrobial and constitute one of the most reliable methods of determining tolerance 141. PAE is the term used to describe the continued suppression of the growth of an organism after a short exposure to an antimicrobial agent [5] . Clinically, the importance of PAE is in antimicrobial agent dosing regimens and it is particularly relevant to short half-life compounds. An infection caused by an organism susceptible to an agent with a significant PAFi may require less fiequent dosing than an infection susceptible to agents that do not demonstrate a PAE, other factors being equal.
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We investigated the rate of killing and PAE of HMR 3004 on aerobic bacteria implicated in upper and lower respiratory tract infections, and, in addition, enterococci and the anaerobe Bucteroides jugilis. The effect of two inocula on the rate of kill was studied. Previous pharmacodynamic studies have shown that erythromycin A is predominantly bacteriostatic, although at hgher concentrations it is slowly bactericidal [6] . Macrolides have demonstrated significant PAEs of > 3 h with staphylococci and streptococci [5] . 
MATERIALS AND METHODS

Bacterial strains and culture conditions
Antimicrobial agent
HMR 3004 was obtained &om Roussel UCLAF, Paris, France. It was stored and prepared throughout these studies using the manufacturer's guidelines.
MIC determinations
MICs were determined for all organisms studied by a broth dilution method 171 with an inoculum of approximately 5 x lo5 CFU/mC. The MIC was defined as the lowest concentration at which there was no visible growth after 18-24 h (48 h for anaerobes) of incubation at 35-37 "C.
Time kill kinetics
HMR 3004 stock solutions were added to logarithmicphase broth cultures of approximately lo5 and lo7 CFU/mL, to give concentrations equivalent to 2 and 10xMIC. An antibiotic-f?ee growth control was included at both inocula. Viable counts were performed (three replicates) at 0, 2, 4, 6 and 24 h after antibiotic addition, by the Miles and Misra technique [8], on agar plates following serial dilution in phosphate-buffered sahne, pH 7.3 (Unipath). The bacteria were enumerated after 48 h of incubation at 35-37°C and the time kill kinetics were plotted as loglo CFlJ/mC against time. Bactericidal activity is defined as a 3 loglo decrease in CFU/mL (99.9% kill) [4] . The lower limit of bacterial enumeration using this method was 2.7 loglo CFU/mL. Bacteriostatic activity was defined a: a < 2 loglo decrease in CFU/mL. Antibiotic carryover was not deemed to be a problem in our determinations as this occurs at higher concentrations of >16xMIC [4] and serial dilution was employed, whch minimizes any carryover effects.
Postantibiotic effect
HMR 3004 stock solutions were added to logarithmicphase broth cultures of approximately lo5 CFU/mC, to give concentrations equivalent to 1 , 4 and 10 x MIC, and a ketolide-free culture was included as a growth control. The cultures were incubated at 35-37°C for 1 h. The HMR 3004 concentration:; were then reduced by 1000-fold dilution into prewarined broth and the cultures were incubated at 35-37°C for 24 h. The control cultures were treated in exxtly the same way. Viable counts were performed on antibiotic-bee agar plates prior to exposure, hourly fcbr 6 h and at 24 h after neutralization by dilution. Viable counts were determined with a spiral plater @on Whitley Scientific Ltd) following appropriate dilution in phosphatebuffered saline, pH 7.3. The bacteria were enumerated after 24 h of incubation at 35-37°C. The counts of loglo CFU/mL were plotted against time, and the PAE was defined as PAE = T -C, where T is the time required for the count in the test culture to increase 1 loglo above the count observed immediately after dilution, and C is the time required for the count in the control to increase 1 loglo above the count observed immediately after ddution [5] . A significant PAE is defined as >0.5 h. approximately l o 5 CFU/mL. Table 1 summarizes the bactericidal rates (change in loglo CFU/mL from 0 to 24 h) of HMR 3004 on all strains investigated in this study. Bactericidal activity is defined as a 3 loglo decrease in CFU/mL; however, in some instances when studying the 10' CFU/mL inoculum a 3 loglo decrease could not be determined (due to lower limit of detection) but a decrease of > 2 loglo was observed. In these cases, if no regrowth was observed for the duration of the experiment, the effect was termed bactericidal. 3004 exhibited a sipficant PAE with all strains studied at 4 and 10 x MIC. The PAEs at 1, 4 and 10 x MIC of HMR 3004 were 0-3.5, 1.1-5.5 and 1.9-6.2h, respectively.
RESULTS
MlCs
DISCUSSION
Our MIC data confirm the preliminary study by Agouridas et al [3] , in that the ketolides have activity against respiratory pathogens and enterococci. The time kill kinetic data demonstrate that HMR 3004 exhibits concentration-and inoculum-dependent bacteriostatic activity on all strains studied. Slow timedependent bactericidal activity (99.9% kill at 24 h) was only seen at the hgher concentration stuhed, but not [6] . Regrowth was observed during this study, and the colonies observed were morphologically identical and had MICs the same as or within one dilution step of the controls. The clinical importance of regrowth is unclear, particularly if it occurs after the usual dosing interval [4] . Bacterial growth suppression termed PAE has been observed since the advent of antibiotic therapy The mechanism and relevance of PAE are still poorly understood, but clinically, its greater impact is on designing dosing regimens for new antimicrobials. There is inadequate clinical evidence to suggest an optimal dosage regimen for macrolides. The most common explanations for the mechanism of PAE are prolonged persistence of the antimicrobial at the cellular site of action or the true recovery period fi-om non-lethal damage [5] . For macrolides, the duration of the PAE may be equivalent to the time required for the macrolide to detach &om the ribosome. H M R 3004 produced a significant concentration-dependent PAE. In conclusion, it would appear that HMR 3004 exhibits pharmacodynamic properties similar to those of erythromycin A, i.e. they are slowly bactericidal at high concentrations and exhibit a significant PAE.
